CNO Evil? Considerations for the Use of DREADDs in Behavioral Neuroscience
Neuropsychopharmacology
.
2018 Apr;43(5):934-936.
doi: 10.1038/npp.2017.299.
Epub 2018 Feb 7.
Authors
Stephen V Mahler
1
,
Gary Aston-Jones
2
Affiliations
1
Department of Neurobiology and Behavior, University of California, Irvine, CA, USA.
2
Brain Health Institute, Rutgers University, Piscataway, NJ, USA.
PMID:
29303143
PMCID:
PMC5854815
DOI:
10.1038/npp.2017.299
No abstract available
Publication types
Comment
MeSH terms
Clozapine*
Designer Drugs*
Neurosciences*
Substances
Designer Drugs
Clozapine
Grants and funding
R00 DA035251/DA/NIDA NIH HHS/United States
R01 DA006214/DA/NIDA NIH HHS/United States